Literature DB >> 624031

Toxicity of oral adjuvant chemotherapy in breast cancer.

J G Murray, J MacIntyre, D P Leiberman, D J Leaper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 624031      PMCID： PMC1603020          DOI： 10.1136/bmj.1.6110.408-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.

Authors:  G Bonadonna; A Rossi; P Valagussa; A Banfi; U Veronesi
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).

Authors:  B Fisher; A Glass; C Redmond; E R Fisher; B Barton; E Such; P Carbone; S Economou; R Foster; R Frelick; H Lerner; M Levitt; R Margolese; J MacFarlane; D Plotkin; H Shibata; H Volk
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860
  2 in total
  3 in total

Review 1.  Review of general surgery 1978.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

2.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

3.  Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate.

Authors:  A Bennett; J D Gaffen; P B Melhuish; I F Stamford
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.